Company Filing History:
Years Active: 2020
Title: Yibing Wang: Innovator in Glycoside Compounds
Introduction
Yibing Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of glycoside compounds, particularly in the development of C,O-spiro aryl glycoside compounds. His work has implications for treating various diseases, including diabetes and atherosclerosis.
Latest Patents
Yibing Wang holds 1 patent for his invention titled "C,O-spiro aryl glycoside compounds, preparation therefor and use thereof." This patent provides detailed descriptions of C,O-spiro aryl glycoside compounds represented by a specific formula. The patent outlines methods for preparing and utilizing these compounds, which can serve as SGLT2 inhibitors for treating diseases such as diabetes, atherosclerosis, and adiposity.
Career Highlights
Yibing Wang is affiliated with the Chinese Academy of Sciences, where he conducts his research and development. His work has garnered attention for its potential applications in medical treatments and pharmaceutical advancements.
Collaborations
Yibing Wang collaborates with notable colleagues, including Hong Tao Liu and Jia Tao Li. Their combined expertise contributes to the innovative research being conducted at the Chinese Academy of Sciences.
Conclusion
Yibing Wang's contributions to the field of glycoside compounds highlight his role as an influential inventor. His patented work has the potential to impact the treatment of significant health issues, showcasing the importance of innovation in science and medicine.